Relic Technologies Ltd (RELICTEC) is currently trading at 64.83 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Relic Technologies Limited is a small, listed Indian company originally focused on share broking that has formally altered its corporate objects to enter pharmaceuticals, nutraceuticals, wellness and allied products trading, and operates through subsidiaries including Relic Pharma Limited and Truhealthy Wellness Private Limited following a strategic pivot approved in 2025. In the latest quarter Relic reported consolidated total income of Rs. 57.86 lakhs and a consolidated net loss of Rs. 102.75 lakhs, while its standalone entity reported total income of Rs. 64.15 lakhs and a standalone net profit of Rs. 21.47 lakhs, highlighting a material earnings divergence between parent and consolidated group results. The Group has commenced revenue from trading activities in pharmaceuticals, nutraceuticals, wellness and healthcare products during the quarter, reflecting execution of the altered object clause and a strategic repositioning; management is contemplating a name change to Relic Life Science Ltd to better reflect the new focus and to support commercial rebranding. Consolidated cost structure shows very high employee expenses and other operating costs relative to revenues, contributing to steep quarterly losses and negative retained earnings on consolidation; this creates liquidity and scalability challenges unless management materially improves gross margins, reduces fixed costs, or secures higher-volume distribution contracts. The pivot into pharma and wellness creates a clear addressable market opportunity for Relic to leverage its listed status and institutional relationships, but meaningful growth will require commercial scale, regulatory compliance (licences, approvals), supplier partnerships, and disciplined working-capital management to convert modest initial trading revenues into sustainable profitability.

Over the past 52 weeks, Relic Technologies Ltd has traded between a low of ₹52.02 and a high of ₹91.45. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Relic Technologies Ltd has a market capitalization of approximately 36.88. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Relic Technologies Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -8.60 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 36.88 Cr, Relic Technologies Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Relic Technologies Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Relic Technologies Ltd is -8.60. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Relic Technologies reported a Q2 FY27 net loss of Rs 3.32 lakh in the supplied live market tracking data. Separately, its standalone business recorded net profit of Rs 24.26 lakh for the quarter ended September 30, 2026.

Relic Technologies reported a consolidated net loss of ₹1.03 crore for the quarter ended June 30, 2026 (Q1FY27).